Vortrag
Baseline Medical Conditions Do Not Impact the Efficacy and Safety of the Adjuvanted Recombinant Zoster Vaccine: a Post-hoc Analysis of Pooled Data from Two Parallel Randomized Trials
Speaker
Datum:
06.05.2019 ,
Zeit:
10:14
|
Thema: Prävention und Rehabilitation
Vortrag
The Impact of Reactogenicity after Administration of the Recombinant Zoster Vaccine upon the Physical Functioning and Quality of Life of Older Adults
Speaker
Datum:
06.05.2019 ,
Zeit:
10:35
|
Thema: Prävention und Rehabilitation